This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- München, DE (2002 - 2003)
- Hattersheim, DE (2003)
Company Filing History:
Years Active: 2002-2003
Title: Detlef Kozian: Innovator in Genetic Research
Introduction
Detlef Kozian is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of genetic research, particularly in the development of innovative methods for gene detection and characterization. With a total of 3 patents, his work has had a notable impact on the scientific community.
Latest Patents
Kozian's latest patents include groundbreaking inventions such as a two-color differential display method for detecting regulated genes. This innovative approach enhances the ability to identify gene expression patterns. Additionally, he has developed a promoter for the functional characterization of G-protein coupled receptors in the yeast Saccharomyces cerevisiae. This invention relates to a promoter, DNA fragments containing said promoter, and their use in identifying substances that exhibit activating or inhibiting actions on G protein-coupled receptors.
Career Highlights
Detlef Kozian is currently employed at Aventis Pharma Deutschland GmbH, where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Birgit Reuner and Almut Nitsche, who have contributed to various projects alongside Kozian. Their collaborative efforts have further enriched the research environment at Aventis Pharma.
Conclusion
Detlef Kozian's innovative contributions to genetic research and his active role at Aventis Pharma highlight his importance in the scientific community. His patents reflect a commitment to advancing our understanding of gene regulation and receptor functionality.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
